digestive/alimentary system
|
• 22.7% of mice injected with tamoxifen develop colonic dysplasia at 15 months post injection
|
|
• 9.1% of mice develop colon cancer at 15 months post injection with tamoxifen
|
homeostasis/metabolism
|
• mice treated with colonic carcinogen azoxymethane (AOM) show higher tumor incidence (100%) compared to treated wild-type mice (67%) and have an increase in tumor number and burden compared with controls
|
neoplasm
|
• 9.1% of mice develop colon cancer at 15 months post injection with tamoxifen
|
|
• mice treated with colonic carcinogen azoxymethane (AOM) show higher tumor incidence (100%) compared to treated wild-type mice (67%) and have an increase in tumor number and burden compared with controls
|


Analysis Tools